Research Antibodies and Reagents Market Worth $6.32 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research

Research Antibodies and Reagents Market Worth $6.32 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research

PR Newswire

LONDON, Nov. 18, 2020

LONDON, Nov. 18, 2020 /PRNewswire/ -- According to a new market research report "Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027", published by Meticulous Research, the research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to reach $6.32 billion by 2027.

Meticulous_Research_Logo

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5055

Impact of COVID-19 on the Research Antibodies and Reagents Market

The COVID-19 pandemic has had a huge impact on the overall healthcare industry. There is currently no specific treatment for COVID-19. Researchers worldwide are investigating preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines, and antivirals, and investigating the repurposing of existing drugs to treat the infection.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5055

Key Findings in the Research Antibodies and Reagents Market Study

The research antibodies and reagents market study present historical market data in terms of value (2018 and 2019), estimated current data (2020), and forecasts for 2027 by product, technology, application, and end user. The study also evaluates industry competitors at the regional and country levels.

Based on product, the research antibodies segment is expected to command the largest share of the overall research antibodies and reagents market in 2020 due to growing protein or cell-based research, increasing funding for the R&D sector, rising need for disease-specific biomarkers, and widespread application in biomarker discovery.

In 2020, based on end-user, the pharmaceutical & biotechnology industry segment is poised to command the largest share of the overall research antibodies and reagents market due to rising research activities with a growing number of diseases, the need for biomarker discovery for better diagnosis & therapy, and increasing drug development programs.

In 2020, geographically, North America is projected to dominate the global research antibodies and reagents market, followed by Europe and Asia-Pacific. Factors such as a well-established healthcare system, acceptance of advanced technologies, rising non-communicable diseases, increasing drug discovery programs & related rise in pharmaceutical research & development, rising focus on proteomics and genomics research, higher research funding, and presence of key players are driving the growth of this market.

Quick Buy – Research Antibodies and Reagents Market Research Report: https://www.meticulousresearch.com/buy_now.php?pformat=356&vformat=1055 

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past few years. The key players operating in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/research-antibodies-reagents-market-5055/

Scope of the Report:

Research Antibodies and Reagents Market, by Product

Research Antibodies and Reagents Market, by Technology

Research Antibodies and Reagents Market, by Application

Research Antibodies and Reagents Market, by End User

Research Antibodies and Reagents Market, by Geography

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5055

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.php

Related Reports:

Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area (Oncology, Immunology), End User (Pharma and Biotech, Medical Device), and Geography - Forecast to 2027

https://www.meticulousresearch.com/product/CRO-market-5129/

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027

https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110/

Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027

https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

https://www.meticulousresearch.com/product/COVID-19-impact-assessment-health-and-life-sciences-industry-5098/

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/press-release/research-antibodies-reagents-market-2027/514    

Logo: https://mma.prnewswire.com/media/1213534/Meticulous_Research_Logo.jpg

 

Voltar noticias em Inglês